Noncommunicable HUMAN adenovirus as a vector for replacement GENE THERAPY angiogenesis disorder, provides an efficient synthesis of human angiogenin in transfected mammalian cells, a method of inducing angiogenesis, METHOD OF TREATMENT ischemic disease, composition for inducing angiogenesis and treatment of ischemic illness

摘要

1. u043du0435u0438u043du0444u0435u043au0446u0438u043eu043du043du044bu0439 u0434u043bu00a0 human adenovirus as vector to gene therapy of u0434u043bu00a0 u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 (for example with u0430u0434u0435u043du043eu0432u0438u0440u0443u0441u0430 birds CELO and gene and, u043au043eu0434u0438u0440u0443u044eu0449u0435u0433u043e angiogenin rights) with the following properties:;- u00a0u0432u043bu00a0u0435u0442u0441u00a0 u0440u0435u043fu043bu0438u043au0430u0442u0438u0432u043du043e - defective cells in mammals (u0432u043au043bu044eu0447u0430u00a0 rights);;in the field, a minor u0434u043bu00a0 replication in the cells of the birds, is u044du043au0441u043fu0440u0435u0441u0441u0438u043eu043du043du0443u044e tape, u0441u043eu0441u0442u043eu00a0u0449u0443u044e of cmv promoter or gene, u043au0434u043du043a u0430u043du0433u0438u043eu0433u0435u043du0438u043du0430 rights and the signal u043fu043eu043bu0438u0430u0434u0435u043du0438u043bu0438u0440u043eu0432u0430u043du0438u00a0 ox growth hormone;;provides u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 induction.;2. method of induction u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430, comprising a body of a mammal u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 induction factor, however, that, as such, use re u043au043eu043cu0431u0438u043du0430u043du0442u043du044bu0439 adenovirus on 1, constructed on the basis of both u043du0435u0438u043du0444u0435u043au0446u0438u043eu043du043du043eu0433u043e u0430u0434u0435u043du043eu0432u0438u0440u0443u0441u0430 birds, in an effective amount.;3. method u043bu0435u0447u0435u043du0438u00a0 coronary heart disease, including the system factor induction u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, as such use u0440u0435u043au043eu043cu0431u0438u043du0430u043d u0442u043du044bu0439 adenovirus birds at 1 in an effective amount.;4. u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 u0434u043bu00a0 induction u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 and u043bu0435u0447u0435u043du0438u00a0 coronary heart disease, u0432u043au043bu044eu0447u0430u044eu0449u0430u00a0 factor induction u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 and physiologically acceptable solvent, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0 u0441u00a0 because as a factor in the induction u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 contains a recombinant adenovirus birds at 1 in an effective amount.